1,734 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
Siemens Medical Solutions USA recalled 20 Artis Pheno. Image-Intensified Fluoroscopic X-Ray Systems due to limited system movements after startup. The recall, announced on August 12, 2025, affects devices distributed nationwide across several states.
Viona Pharmaceuticals recalled 3,960 bottles of Tavaborole Topical Solution on August 12, 2025. The product may show discoloration, posing health risks to consumers. This recall affects topical solutions distributed nationwide in the USA.
Max Mobility recalled 8,413 Smart Drive MX2+ SpeedControl Dials on August 12, 2025. A faulty electrical connection poses a risk of losing control of the wheelchair, leading to potential injuries. Healthcare providers should stop using the device immediately and follow recall instructions.
Max Mobility recalled 25,389 Smart Drive MX2+ SpeedControl Dials on August 12, 2025. A faulty electrical connection can lead to loss of control, posing injury risks. Users must stop using the device immediately and follow recall instructions.
Applied Medical Technology recalled 1,780 NutraGlide Nasal Feeding Tubes on August 12, 2025, after reports of distal tips detaching. This recall affects tubes distributed in Massachusetts and Rhode Island. The detachment poses a high risk for patients requiring enteral nutrition.
Applied Medical Technology recalled 390 NutraGlide Nasal Feeding Tubes on August 12, 2025, due to a risk of distal tips detaching. This recall affects models distributed in Massachusetts and Rhode Island. Patients and healthcare providers must stop using these devices immediately.
Applied Medical Technology recalled 840 NutraGlide Nasal Feeding Tubes on August 12, 2025. The tubes may have distal tips that detach unexpectedly, posing a risk to patients. Healthcare providers and patients must stop using the device immediately and follow recall instructions.
Applied Medical Technology recalled 200 NutraGlide Nasal Feeding Tubes on August 12, 2025. The distal tips may detach under lower than expected forces, posing a risk to patients. This recall affects devices distributed in Massachusetts and Rhode Island.
Agilent Technologies Denmark ApS recalled 65 units of its FLEX Monoclonal Mouse Anti-Human CD20cy, Clone L26 on August 11, 2025. The recall stems from potential weak staining that could lead to false negative CD20 identification. Healthcare providers and patients should stop using the product immediately.
Agilent Technologies recalled 67 units of FLEX Monoclonal Mouse Anti-Human CD20cy on August 11, 2025. The recall stems from the potential for weak staining leading to false negative results in B-cell identification. Healthcare providers must cease use immediately and follow recall instructions.
Agilent Technologies Denmark ApS recalled 4,145 units of FLEX Monoclonal Mouse Anti-Human CD20cy on August 11, 2025. The recall stems from potential weak staining that may lead to false negative CD20 identification. Healthcare providers and patients must stop using the product immediately.
Lannett Company recalled 8,544 bottles of Lisdexamfetamine Dimesylate Capsules on August 11, 2025. The recall occurred due to a labeling mix-up where 40 mg capsules were mislabeled as 30 mg. This issue poses a high risk to consumers who may receive incorrect dosages.
Baxter Healthcare Corporation recalled 14,400 units of its Continu-Flo solution set on August 8, 2025. The recall follows customer reports of tubing separation that pose serious risks. Healthcare providers and patients must stop using the device immediately.
Glenmark Pharmaceuticals Inc. recalled 22,656 bottles of Theophylline extended-release tablets on August 8, 2025. The recall follows reports of failed dissolution specifications that could impact medication efficacy. Consumers should stop using the product and consult healthcare providers immediately.
Philips Medical Systems Nederland B.V. recalled its IntelliSpace Cardiovascular Software 8.0.0.4 on August 8, 2025. The recall affects four units distributed nationwide, particularly in Georgia, North Carolina, and Texas. The software displays outdated information, posing a significant risk to patient safety.
Quallent Pharmaceuticals recalled 3,591 bottles of Duloxetine Delayed-Release Capsules on August 8, 2025. The recall stems from CGMP deviations regarding an impurity exceeding safety limits. Consumers should stop using the product immediately and contact their healthcare provider.
Schiller Ag recalled 266 units of the Argus PB-3000 on August 8, 2025. The vital sign monitoring instrument may trigger an error message during blood pressure measurements. The recall affects devices distributed nationwide in Montana, Wisconsin, and Illinois.
Medline Industries recalled 88 units of its Sterile Convenience Kits on August 8, 2025. The kits were labeled as sterile but did not undergo the required sterilization process. Healthcare providers and patients must stop using these kits immediately.
Medline Industries recalled 22 sterile convenience kits on August 8, 2025, after discovering they had not been sterilized. The affected models include DYNJ0382730O and DYNJ61038B. This recall impacts states including Florida, Maryland, New Jersey, and Tennessee.
Glenmark Pharmaceuticals recalled 4,800 bottles of Carvedilol Tablets on August 7, 2025. The recall stems from CGMP deviations leading to high levels of nitrosamine impurities. Consumers should stop using the product immediately and consult healthcare providers for guidance.
Guangzhou Ariel Biotech recalled Séfralls Hair Generation Serum on August 7, 2025. The recall affects an unknown number of units due to the product's non-compliance with child-resistant packaging standards. The defective packaging poses a serious poisoning risk to children if ingested.
Glenmark Pharmaceuticals recalled 6,432 bottles of Carvedilol Tablets on August 7, 2025. The recall stems from CGMP deviations due to the presence of a nitrosamine impurity above acceptable levels. Consumers should stop using the product immediately and contact healthcare providers for guidance.
Glenmark Pharmaceuticals recalled 44,328 bottles of Carvedilol Tablets, USP, 3.125 mg on August 7, 2025. The recall follows the discovery of N-Nitroso Carvedilol I impurity above acceptable levels. Consumers should stop using this medication immediately and consult their healthcare providers.
Glenmark Pharmaceuticals recalled 14,976 bottles of Carvedilol Tablets on August 6, 2025. The recall follows findings of N-Nitroso Carvedilol Impurity-1 above FDA limits. Consumers should stop using the product immediately and contact their healthcare provider.
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.